glp 1 cardiovascular risk GLP-1s and Heart Health: Cardiometabolic GLP-1 receptor agonist-based therapies and

doi: 10.1016/j.neurobiolaging.2012.04.009 178 OhtakeNSaitoMEtoMSekiK

Turner RS, Thomas RG, Craft S, et al

-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells

Just bioavailable stress-fighting nutrients

Omega-3 supplementation seems to be an option that can be effective in improving the lipid profile and reducing cardiovascular risk, as metabolic nuclear receptors like PPAR and SREBP-1 (sterol regulatory element-binding protein 1) are activated by the binding of natural lipid-derived ligands such as fatty acids, allowing the inhibition of protein-coding that stimulates lipid synthesis and genes that increase lipid oxidation in the liver and muscle